Epitomee Medical Ltd (EPIT) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.01x

Epitomee Medical Ltd (EPIT) has a Cash Flow Reinvestment Rate of 0.01x as of December 2020, reinvesting ILA179.29K (capex ILA179.29K ) from operating cash flow of ILA27.75 Million. Explore EPIT capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

ILA179.29K
Capex + Investments

Operating Cash Flow

ILA27.75 Million
ILA

Capital Expenditures

ILA179.29K
ILA

Epitomee Medical Ltd Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Epitomee Medical Ltd across 1 annual periods. Also explore EPIT total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Epitomee Medical Ltd (2020–2020)

Year-by-year capital reinvestment analysis for Epitomee Medical Ltd. For live market cap and broader valuation context, see market cap of Epitomee Medical Ltd.

Year Reinvestment Rate Total Reinvested (ILA) Operating CF Capex YoY Change
2020 2.33x ILA15.74 Million ILA6.75 Million ILA104.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow